Friedreich's Ataxia Completed Phase 3 Trials for Interferon gamma-1b (DB00033)

Back to Friedreich's Ataxia

Also known as: Friedreich Ataxia / Friedreich's ataxia (disorder)

IndicationStatusPhase
DBCOND0037758 (Friedreich's Ataxia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02415127Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's AtaxiaTreatment
NCT02593773Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia StudyTreatment
NCT02797080Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's AtaxiaTreatment